RxDoctor Payments Data

Paul Brown, PA

Physician Assistant · Huron, SDNPI 1649682428

Payments from drug & device makers

$994in general payments, 2019–2025

Across 59 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$214
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$115
  • Johnson & Johnson$110
  • Lilly USA, LLC$70
  • Boehringer Ingelheim$61
  • Merck$58
  • plus $367 from 14 others

What the payments were for

  • Food & beverage$994100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$994 in reported general payments places this provider in the 75th percentile of 548 physician assistant providers in South Dakota.

See all physician assistant providers in South Dakota

Medicare billing

Part B allowed, 2024
$3,204
Medicare patients
54
Services billed
284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter65$44,107
FarxigaDapagliflozin Propanediol52$34,007
Invega SustennaPaliperidone Palmitate12$29,173
JardianceEmpagliflozin30$17,015
EliquisApixaban27$16,790
MounjaroTirzepatide12$12,649
Tresiba Flextouch U-100Insulin Degludec20$9,703
LinzessLinaclotide17$9,324
XareltoRivaroxaban14$8,143
Jentadueto XrLinagliptin/Metformin Hcl13$5,979
Janumet XrSitagliptin Phos/Metformin Hcl12$5,414
Bevespi AerosphereGlycopyrrolate/Formoterol Fum11$5,033
Sucralfate30$3,202
Gabapentin99$2,282
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$1,160

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$12$44,10765 claims
AstraZenecaFarxiga, Bevespi Aerosphere$40$39,04063 claims
Johnson & JohnsonInvega Sustenna, Xarelto$110$37,31526 claims
Boehringer IngelheimJardiance, Jentadueto Xr$61$22,99443 claims
PfizerEliquis, Dilantin$28$17,38640 claims
Lilly USA, LLCMounjaro, Olanzapine$70$12,99525 claims
AbbVieLinzess$214$9,32417 claims
MerckJanumet Xr$58$5,41412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 548 physician assistant providers in South Dakota.

Other physician assistant in Huron

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →